Cancer meets its nemesis

• Autores: Andy Coghlan
• Localización: New scientist, ISSN 0262-4079, Nº. 2944, 2013, págs. 6-7
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Cancer researcher Michel Sadelain is admirably understated about the success of a treatment developed in his lab at the Memorial Sloan-Kettering Cancer Center in New York. In March, he announced that five people with a type of blood cancer called acute lymphoblastic leukemia were in remission following treatment with genetically engineered immune cells from their own blood. One person's tumors disappeared in just eight days. Sadelain has now told New Scientist that a further 11 people have been treated, almost all of them with the same outcome. Several trials for other cancers are also showing promise.